Published date: 4 November 2021
Last edited date: 5 November 2021
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Research and development consultancy services - 73200000
Location of contract
SE1 6LH
Value of contract
£75,000
Procurement reference
CF-0453800D0O000000rwimUAA2
Published date
4 November 2021
Closing date
18 November 2021
Closing time
2pm
Contract start date
1 December 2021
Contract end date
31 March 2022
Contract type
Service contract
Procedure type
Open procedure (below threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements below the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
Yes
Description
The provision of a research study to ascertain the medication safety benefits that the introduction of Interoperable Medicines Standards will generate in practice.
To review the competition documents and submit a bid please follow this link:
https://health-family-contract-search.secure.force.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a074J00000HQZgiQAH&searchStr=&sortStr=Recently+Published&page=1&filters=&County=
More information
Previous notice about this procurement
Research into Medicines Interoperability Benefits
- Opportunity
- Published 4 November 2021
Links
About the buyer
Contact name
Charlie Stephens
Address
Skipton House
London
SE1 6LH
GB
Telephone
07702406206
Share this notice
Closing: 18 November 2021, 2pm